This page collects WhisperX intelligence signals tagged #Equity Financing. It is designed for humans, search engines, and AI agents: each item links to a canonical source-backed record with sector, source, timestamp, credibility, and exportable structured data.
CarParts.com has entered into a definitive agreement for a $50 million private placement of its common stock, a significant capital raise conducted outside of public markets. The unregistered sale of equity securities, disclosed in an 8-K filing with the SEC, points to a pressing need for liquidity or a strategic pivot...
Artelo Biosciences, Inc. has filed a significant 8-K form with the SEC, signaling multiple material corporate developments. The filing, submitted on March 26, 2026, includes disclosures under Item 1.01 for entering into a material definitive agreement, Item 3.02 for an unregistered sale of equity securities, and Item 7...
PetVivo Holdings, Inc. has filed an amended 8-K form with the SEC, disclosing significant corporate actions that signal a shift in its financial and operational posture. The filing flags three critical items: the entry into a material definitive agreement, an unregistered sale of equity securities, and the inclusion of...
Pluri Inc. has filed a significant 8-K form with the SEC, disclosing two major corporate actions that signal a pivotal financial and strategic shift. The filing, submitted on March 27, 2026, formally announces the company's entry into a material definitive agreement and the concurrent sale of unregistered equity securi...
American Rebel Holdings, Inc. has been hit with a critical Nasdaq delisting notice, signaling a severe compliance failure that threatens its public market status. The company's latest 8-K filing reveals a cascade of material events, including the entry into a new definitive agreement and the unregistered sale of equity...
Pulmatrix, Inc. has filed a comprehensive 8-K form with the SEC, detailing a series of material corporate events that collectively signal a significant restructuring of the company. The filing, submitted on March 27, 2026, lists multiple critical items including a change in control, unregistered equity sales, and amend...
SCYNEXIS, Inc. has filed a significant 8-K form with the SEC, disclosing multiple material events that signal a period of active corporate restructuring and strategic financial moves. The filing, submitted on March 31, 2026, includes entries for a material definitive agreement, unregistered sales of equity securities, ...
Cadrenal Therapeutics, Inc. has filed a significant 8-K form with the SEC, disclosing multiple material corporate events in a single filing. The company has entered into a material definitive agreement, conducted an unregistered sale of equity securities, and materially modified the rights of its security holders. Thes...
Bed Bath & Beyond has filed a significant 8-K form with the SEC, revealing a multi-faceted corporate restructuring event. The filing, submitted on April 2, 2026, details a series of material developments including the entry into new binding agreements, unregistered sales of company equity, and notable changes to its bo...
Trans American Aquaculture, Inc. has filed a significant 8-K form with the SEC, disclosing two material corporate events that signal a potential strategic shift or financial maneuver. The filing, submitted on April 2, 2026, formally reports the company's entry into a Material Definitive Agreement and the execution of a...
Silo Pharma, Inc. has filed a Form 8-K with the SEC, disclosing two significant corporate actions that point to a potential strategic pivot or urgent financial maneuver. The filing flags the company's entry into a "Material Definitive Agreement" and the execution of an "Unregistered Sale of Equity Securities," a combin...
Aytu BioPharma has filed a dense 8-K form with the SEC, disclosing a series of significant corporate actions that point to a substantial operational and financial restructuring. The filing, submitted on April 2, 2026, bundles multiple material events, including the entry into a definitive agreement, the reporting of fi...
Ensysce Biosciences, Inc. has filed a significant 8-K form with the SEC, disclosing multiple material events that signal a period of active corporate restructuring or financing. The filing, submitted on April 8, 2026, includes three key items: the entry into a material definitive agreement, an unregistered sale of equi...
AquaBounty Technologies has triggered a significant corporate event, filing an 8-K form with the SEC detailing a multi-faceted restructuring. The filing, submitted on April 8, 2026, reveals the company has entered into a material definitive agreement, conducted an unregistered sale of equity securities, materially modi...
Odyssey Marine Exploration has filed a dense, 18-megabyte 8-K form with the SEC, signaling a significant corporate event. The filing, submitted on April 8, 2026, bundles multiple material disclosures into a single report, indicating a period of substantial operational and financial activity for the deep-sea exploration...
Prairie Operating Co. has filed a significant 8-K form with the SEC, disclosing multiple material events that signal a major corporate shift. The filing, submitted on April 9, 2026, reveals the company has entered into a material definitive agreement, conducted unregistered sales of equity securities, and materially mo...
Beneficient has filed a significant 8-K form with the SEC, disclosing a series of material corporate actions that point to a substantial internal restructuring. The filing, submitted on April 10, 2026, reveals unregistered sales of equity securities, material modifications to the rights of security holders, and amendme...
BiomX Inc. has filed a dense 8-K form with the SEC, signaling a significant corporate event involving multiple material developments. The filing, submitted on April 10, 2026, encompasses a completion of an asset acquisition, unregistered sales of equity securities, and the entry into new definitive agreements, all of w...
VisionWave Holdings, Inc. has filed a significant 8-K form with the SEC, disclosing multiple material corporate actions in a single filing. The company has entered into a definitive agreement, completed an acquisition or disposition of assets, and conducted an unregistered sale of equity securities. This cluster of eve...
BiomX Inc. has filed a dense 8-K form with the SEC, signaling a significant corporate event involving multiple material developments. The filing, submitted on April 13, 2026, encompasses a completion of an asset acquisition, unregistered sales of equity securities, and the entry into new definitive agreements, all of w...